Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Not yet recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 14OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Urinary Bladder Neoplasms 17Colorectal Neoplasms 17Non-Muscle Invasive Bladder Neoplasms 10Neoplasm Metastasis 10Stomach Neoplasms 9Appendiceal Neoplasms 9Anus Neoplasms 9Peritoneal Neoplasms 8Carcinoma, Hepatocellular 8Pancreatic Neoplasms 5Liver Neoplasms 4Colonic Neoplasms 4Pseudomyxoma Peritonei 3Carcinoma, Transitional Cell 3Carcinoma, Non-Small-Cell Lung 3Uterine Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Sarcoma 2Rectal Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Head and Neck Neoplasms 2Gastrointestinal Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Urothelial Carcinoma Ureter 1Urethral Neoplasms 1Ureteral Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1

Interventions

pembrolizumab 37Gemcitabine 29Nivolumab 20Cisplatin 19atezolizumab 15avelumab 14Docetaxel 13enfortumab vedotin 10Carboplatin 10durvalumab 9Magnetic Resonance Spectroscopy 9Ipilimumab 8Paclitaxel 7Pemetrexed 6toripalimab 5cabozantinib 5Fluorodeoxyglucose F18 5sacituzumab govitecan 4cabazitaxel 4Taxes 4vinflunine 3tremelimumab 3pemigatinib 3X-Rays 3Standard of Care 3Specimen Handling 3Radiotherapy 3Mitomycin 3Immunotherapy 3Immunoglobulin G 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Transitional Cell × Mitomycin × Clear all
NCT07189793 2025-09-24

OHAI-NMIBC-01

First Affiliated Hospital of Wenzhou Medical University

Phase 2 Not yet recruiting
106 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms, Carcinoma in Situ, Carcinoma, Transitional Cell

NCT03658304 2024-11-05

Trial of Mitomycin C During Nephroureterectomy for Urothelial Carcinoma

University of Florida

Phase 2 Completed
29 enrolled 11 charts
Genitourinary

Carcinoma, Transitional Cell

NCT06462001 2024-06-17

BCG + MMC: Adding Mitomycin C to BCG in High-risk, Non-muscle-invasive Bladder Cancer

Nottingham University Hospitals NHS Trust

Phase 3 Active not recruiting
500 enrolled
Genitourinary

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡